Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Juan Odendaal invited to training camp in Switzerland
2015-10-19

Juan Odendaal recently in action at the UCI Paralympic World Cup
for road races in Pietermaritzburg.
Photo: Bertus Odendaal

Juan Odendaal from the University of the Free State (UFS) was invited to be part of a training camp in Switzerland, together with some of the world’s leading para-cyclists.

This first-year BA student was recently selected by the cycling body, Union Cyclist International (UCI), to attend the camp which will be held in Aigle from 2-12 November 2015.

Afterwards, Odendaal, who has been the junior South African champion in the C3 division in road races, time trials, and pursuit races, will travel to Manchester, England, where he will compete in a para-cycling event from 13-15 November 2015.

Recently, he took part in the senior division of the UCI Paralympic World Cup for road races for the first time, and has performed well. In this event, which was held in Pietermaritzburg, he competed against participants from countries including Germany, Australia, Spain, and Russia.

Odendaal on 11 September 2015 took eighth place in the road race and tenth place in the time trial. The road race takes place over 55 km and the time trial over 24 km.

Odendaal said he realised immediately that he was competing at senior level.

“There was a marked difference in the quality of the races,” he said, about the World Cup in Pietermaritzburg.

“It was much faster than I had expected. The average speed was 37,2 kilometres per hour.”

Odendaal also made his debut for South Africa in March of this year at the UCI Para-cycling Track World Championships in Apeldoorn, The Netherlands. At this event, he finished in fifteenth place in both the time trials and the pursuit event.

Odendaal said his main goal is the World Championships, which will take place in Montichiari, Italiy, in March 2016. He is hoping to achieve good times there in order to qualify for the 2016 Olympics in Rio de Janeiro.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept